Magnetic Resonance Elastography – noninvasive method to assess liver disease
DOI:
https://doi.org/10.15584/ejcem.2017.2.5Keywords:
fibrosis, liver stiffness, MRE, magnetic resonance imagingAbstract
Currently, liver disease is widespread and the awareness of these diseases is low. Early symptoms of liver disease do not necessarily indicate problems with this organ and patients are usually informed of their problems when the stage of the disease is already advanced. Invasive biopsies are the clinical diagnostic method most commonly used in the evaluation of liver disease. A biopsy is associated with a high risk of false results and additional complications. Finding new non-invasive imaging methods has led to the discovery of a new method called Magnetic Resonance Elastography (MRE). This technique allows one to evaluate the mechanical properties of tissues and to distinguish between pathological states. Testing using this technique can be performed on a conventional magnetic resonance system by using few additional components and properly prepared software. Studies have shown that there is a strong correlation between MRE-measured liver stiffness and the degree of fibrosis. MRE is also useful in characterizing liver tumors. Studies show that this technique is highly credible in both health volunteers and patients with liver fibrosis. MRE has tremendous diagnostic potential. The described technique is not currently widely used and has the potential to serve as a safe and accurate alternative in clinical diagnostics in the future.Downloads
References
Hartleb M, Barański K, Zejda J, Chudek J, Więcek A. Non-alcoholic fatty liver (NAFL) and advanced fibrosis in the elderly: results from a community-based Polish survey. Liver Int. 2017; DOI:10.1111/liv.13471.
Craxi A, Antonucci G, Camma C. Treatment options in HBV. J Hepatol. 2006;44:77–83.
Liaw YF, Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351:1521–1531.
Dienstag JL, McHutchison JG. American gastroenterological ascoication technical review on the management of hepatitis C. Gastroenterology. 2006;130:231–264.
Fernandez-Yunquera A, Rincón D, Salcedo M, Bañares R. Update on the use of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection. Rev Esp Quimioter. 2013;26(3):189-92.
Younossi Z, Koenig A, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of non-alcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence and outcomes. Hepatology. 2015;0:1–67.
Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84.
Fowell A, Iredale J. Emerging therapies for liver fibrosis. Dig Dis. 2006;24:174–183.
Zoubek ME, Trautwein C, Strnad P. Reversal of liver fibrosis: From fiction to reality. Best Pract Res Clin Gastroenterol. 2017;31(2):129-141.
Koyama Y, Xu J, Liu X. New Developments on the Treatment of Liver Fibrosis. Dig Dis. 2016;34:589-596.
Friedman SL. Liver fibrosis- from bench to bedside. Journal of hepatology. 2003;38(1):38–53.
Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol. 2011;25:195–206.
Bravo AA, Sheth SG, Chopra S. Liver biopsy. The New England journal of medicine. 2001;344(7):495–500.
Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005;128(7):1898–906.
Hernando D, Levin YS, Sirlin CB, Reeder SB. Quantification of liver iron with MRI: State of the art and remaining challenges. J Magn Reson Imaging. 2014;40:1003–1021.
Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging. 2011;34:729–749.
Maharaj B, Leary WP, Naran AD, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet. 1986;327:523–525.
Pagliaro L, Rinaldi F, Craxi A, Di Piazza S, Filippazzo G. Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. Dig Dis Sci. 1983;28:39–43.
Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology. 2009;49:1017–1044.
Eisenberg E, Konopniki M, Veitsman E, Kramskay R, Gaitini D, Baruch Y. Prevalence and characteristics of pain induced by percutaneous liver biopsy. Anesth Analg. 2003;96:1392–1396.
Fernandez-Salazar L, Velayos B, Aller R, Lozano F, Garrote JA, Gonzalez JM. Percutaneous liver biopsy: patients' point of view. Scand J Gastroenterol. 2011;5521:1–5.
Tang A, Cloutier G, Szeverenyi NM, Sirlin CB. Ultrasound elastography and MR elastography for assessing liver fibrosis: Part 2, diagnostic performance, confounders, and future directions. Am J Roentgenol. 2015;205:33–40.
Muthupillai R, Lomas D, Rossman P, et al. Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science. 1995;269:1854–1857.
Rouvière O, Yin M, Dresner M, et al. MR elastography of the liver: preliminary results. Radiology. 2006;240:440–448.
Huwart L, Peeters F, Sinkus R, et al. Liver fibrosis: non-invasive assessment with MR elastography. NMR Biomed. 2006;19:173–179.
Yin M, Talwalkar J, Glaser K, et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol. 2007;5:1207–1213.
Tan C, Venkatesh S. Magnetic Resonance Elastography and Other Magnetic Resonance Imaging Techniques in Chronic Liver Disease: Current Status and Future Directions. Gut Liver. 2016;10(5):672-86.
Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging. 2013;37:544–555.
Moran PR. A flow velocity zeugmatographic interlace for NMR imaging in humans. Magn Reson Imaging. 1982;1:197–203.
Huwart L, Sempoux C, Vicaut E, et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology. 2008;135:32–40.
Venkatesh S, Yin M, Glockner J, et al. MR Elastography of Liver Tumors. Proceedings 16th Scientific Meeting, International Society for Magnetic Resonance in Medicine; Toronto. 2008;a.p.2781.
Lee V, Miller F, Omary R, et al. Magnetic resonance elastography and biomarkers to assess fibrosis from recurrent hepatitis C in liver transplant recipients. Transplantation. 2011;92(5):581–586.
Binkovitz LA, El-Youssef M, Glaser KJ, et al. Pediatric MR elastography of hepatic fibrosis: principles, technique and early clinical experience. Pediatr Radiol. 2012;42:402–409.
Yin M, Talwalkar JA, Glaser KJ, et al. Dynamic postprandial hepatic stiffness augmentation assessed with MR elastography in patients with chronic liver disease. AJR Am J Roentgenol. 2011;197:64–70.
Asbach P, Klatt D, Schlosser B, et al. Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR Elastography. Radiology. 2010;257:80–86.
Wang J, Malik N, Yin M, et al. Magnetic resonance elastography is accurate in detecting advanced fibrosis in autoimmune hepatitis. World J Gastroenterol. 2017;23(5):859-868.
Rustogi R, Horowitz J, Harmath C, et al. Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging. 2012;35:1356–1364.
Yin M, Glaser K, Talwalkar J, Chen J, Manduca A, Ehman R. Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations. Radiology. 2016;278(1):114-24.
Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2008;47:380–384.
Loomba R, Sanyal A. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10:686–69.
Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005–2023.
Chen J, Talwalkar J, Yin M, Glaser K, Sanderson S, Ehman R. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology. 2011;259:749-756.
Loomba R, Wolfson T, Ang B. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study. Hepatology. 2014;60:1920-1928.
Kim D, Kim W, Talwalkar J, Kim H, Ehman R. Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. Radiology. 2013;268:411-419.
Imajo K, Kessoku T, Honda Y, et al. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. Gastroenterology. 2016;150:626–637.
Venkatesh S, Yin M, Ehman R. Magnetic Resonance Elastography of Liver: Clinical Applications. J Comput Assist Tomogr. 2013;37(6):887–896.
Patel N, Hooker J, Loomba R, et al. Weight Loss Decreases Magnetic Resonance Elastography Estimated Liver Stiffness in Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology. 2017;15:463–464.
Venkatesh S, Yin M, Glockner J, et al. MR elastography of liver tumors: preliminary results. AJR Am J Roentgenol. 2008;190:1534–1540.
Thompson S, Wang J, Chandan V, et al. MR elastography of hepatocellular carcinoma: Correlation of tumor stiffness with histopathology features—Preliminary findings. Magnetic Resonance Imaging. 2017;37:41 45.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
